You are invited to join EASL at the European Parliament, Brussels, Belgium, for the launch of the research roadmap for liver disease 'HEPAMAP'.
The HEPAMAP is an advocacy tool written specifically for European hepatologists to highlight the further research needed with a view to influencing the EU research agenda, but also to raise awareness of liver disease more generally and its links with lifestyle factors such as obesity and alcohol, as well as with metabolic and cardiovascular disease and cancer.
New study evaluates efficacy of PET imaging to manage chronic liver diseases
EASL governing board announces new Vice-Secretary
A web-based program is as effective as group counseling for patients with non-alcoholic fatty liver disease